Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… N202022 RILPIVIRINE HYDROCHLORIDE TABLET; ORAL EQ 25MG BASE EDURANT TIBOTEC | Complera (emtricitabine, rilpivirine and tenofovir disoproxil fumarate) Fixed Dose Combination Tablets, Gilead Sciences, Inc., Approval | Complera, emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate, Tablet; Oral, Gilead Sciences Inc, Labeling Revision | Edurant, rilpivirine hydrochloride, Tablet; Oral, Janssen Prods, Labeling Revision | Edurant, rilpivirine hydrochloride, Tablet; Oral, Janssen Prods, Efficacy Supplement with Clinical Data to Support | Complera, emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate, Tablet; Oral, Gilead Sciences Inc, Manufacturing Change or Addition | Edurant, rilpivirine hydrochloride, Tablet; Oral, Janssen Prods, Manufacturing Change or Addition | Complera, emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate, Tablet; Oral, Gilead Sciences Inc, Manufacturing Change or Addition ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2013 Betterchem.com